ACS Omega · 2022 · 13 citations · 35 references
Life SciencesInfectious DiseasesMolecular BiologyImmunopharmacologyMolecular VirologyVaccinologyAntimicrobial PeptidesAntiviral ImmunityCell-penetrating PeptidesPeptide ChemistryPeptide Drug DiscoveryAntibacterial PeptidesAntiviral PeptidesMolecular Docking AnalysisMutationPeptide VaccinationSars-cov-2 InfectionTargeting PeptidesTherapeutic Peptides
. Additionally, all peptides had no toxicity to three lines of human cells as well as to zebrafish larvae and embryos. Thus, these peptides have potential activity against SARS-CoV-2, making them promising to develop new drugs to inhibit cell infection by SARS-CoV-2.
35
Remdesivir for the Treatment of Covid-19 — Final Report
John H. Beigel, Kay M Tomashek, Lori E. Dodd et al. · New England Journal of Medicine · 2020 · 7.7K citations · Full text
First Case of 2019 Novel Coronavirus in the United States
Michelle Holshue, Chas DeBolt, Scott Lindquist et al. · New England Journal of Medicine · 2020 · 6.4K citations · Full text
The ClusPro web server for protein–protein docking
Dima Kozakov, David R. Hall, Bing Xia et al. · Nature Protocols · 2017 · 3.3K citations · Full text